Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LMP Investor Relations Inc. was a boutique investor relations and strategic communications firm that specialized in the life sciences and biotechnology sectors. Based in New York, the firm provided specialized financial communications, investor outreach, and public relations services to emerging and mid-cap biopharmaceutical companies. A notable client of the firm was Memory Pharmaceuticals, where LMP managed investor communications during critical clinical development phases. The firm was led by experienced professionals such as Laura Perry, who later transitioned to senior roles at other prominent biotech IR firms like Argot Partners. While the specific entity 'LMP Investor Relations Inc.' is no longer active, its legacy continues through the work of its principals in the healthcare communications industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LMP Investor Relations.